Fund HoldingsJOHNSON & JOHNSON

Total Portfolio Value
$427.33M
Total Bought
$104.8K
Total Sold
$1.44M
Net Transaction
-$1.34M
Filing Period:
Securities
SharesValue ($K)
Q2 2024
Q3 2024
Change
Q2 2024
Q3 2024
Weight (%)
Change
Protagonist Therapeutics Inc.2,449,1832,449,183084,864110,21325.79%+25,349
Procept BioRobotics Corporation(PRCT)357,939357,939021,86628,6786.71%+6,812
Neumora Therapeutics, Inc.1,849,4451,849,445018,18024,4315.72%+6,251
Nanobiotix S.A.(NBTX)5,623,8165,623,816028,11932,3377.57%+4,218
Legend Biotech Corporation(LEGN)814,586814,586036,07839,6959.29%+3,617
Contineum Therapeutics Inc.1,979,1731,979,173034,85337,8818.86%+3,028
Xencor, Inc.(XNCR)748,062748,062014,16115,0443.52%+883
Fate Therapeutics, Inc.3,379,0643,379,064011,08311,8272.77%+743
Clearside Biomedical, Inc.082,481+82,48101050.02%+105
Adicet Bio, Inc.364,472364,47204415250.12%+84
Standard BioTools Inc311,967311,96705526020.14%+50
Senseonics Holdings, Inc.54,62154,621022190.00%-3
Nano-X Imaging Ltd.
ORD SHS
158,852158,85201,1669660.23%-200
MeiraGTx Holdings plc(MGTX)6,641,0646,641,064027,95927,6936.48%-266
Vor Biopharma, Inc.(VOR)1,074,6581,074,65801,0757520.18%-322
BiomX Inc.1,923,201192,321-1,730,8806461960.05%-450
Rallybio Corporation3,636,3633,636,36304,8734,2551.00%-618
Aldeyra Therapeutics, Inc.299,6690-299,6699920-992
Arrowhead Pharmaceuticals, Inc.(ARWR)247,598247,59806,4354,7961.12%-1,639
Rapport Therapeutics, Inc.(RAPP)2,498,0512,498,051058,10551,16011.97%-6,945
CVRx, Inc.4,103,4304,103,430049,20036,1518.46%-13,049
Page 1 of 1